Sativus Tech Corp , the first-ever AgTech company that is developing the protocols to grow saffron using vertical farming technology, has begun an extensive rebranding effort in response to the evolving needs of the agricultural market and to accelerate the company’s growth strategy. The company began to shape its new corporate vision with the change of its name from Seedo Corp to Sativus Tech Corp. The new name allows the company to begin a new brand identity and business strategy to p

Read more...

Ferrer, the international pharmaceutical laboratory based in Barcelona, has become a B Corp company thanks to its positive impact in society and on the planet. The company has exceeded global B Corp standards in terms of social and environment performance, transparency and corporate responsibility in all the territories in which it has a direct presence. With the completion of the certification process, Ferrer is the first Spanish pharmaceutical company to become part of the international B C

Read more...

EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases and cancer, announced a research and development collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology by combining resources and expertise from both sides. The Haihe Laboratory of Cell Ecosystem, run by the Institute of Hematology and B

Read more...

Virica Biotech Inc., a leading developer of solutions for scaling of viral medicines, today announced it will collaborate with Oxford Biomedica plc, a leading gene and cell therapy company, to improve the yield and production efficiency of Oxford Biomedica’s next generation lentiviral vector gene therapies using Virica’s Viral Sensitizers (VSEs™). Ella Korets-Smith, Chief Business Officer of Virica Biotech, said: “There is growing demand from major industry p

Read more...

Sonoma Pharmaceuticals, Inc.  a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has added Salus Medical as an additional distribution partner in the United States for dental care and expanded its oral and dental care lines to China via a partnership deal w

Read more...

InterX Inc. have developed a polarizable force-field/simulation stack that is parameterized by ab-initio data and describes arbitrary neutral organic molecules. The simulation suite achieves solvation results better than chemical accuracy. These findings are published online in Nature Communications: https://www.nature.com/articles/s41467-022-28041-0 About InterX Inc. InterX Inc. is creating the technology to perform molecular simulations with chemi

Read more...

IBM  and Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, today announced that the companies have signed a definitive agreement under which Francisco Partners will acquire healthcare data and analytics assets from IBM that are currently part of the Watson Health business. The assets acquired by Francisco Partners include extensive and diverse data sets and products, including Health Insights, MarketScan, Clinical Development,

Read more...

Medicx Health today announced a partnership with MadHive, the enterprise software that powers modern media, to create a new privacy-compliant end-to-end OTT solution for the healthcare industry. As consumers rapidly cut their cable cords, streaming TV is driving a shift in how, when and where audiences consume content. OTT advertising combines digital advertising's targeting capabilities with linear TV's broad reach and scale, providing advertisers the opportunity to reach i

Read more...